Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid
- 1 September 2005
- Vol. 66 (3) , 658.e1-658.e3
- https://doi.org/10.1016/j.urology.2005.03.028
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 casesJournal of Oral Pathology & Medicine, 2005
- Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: A new clinical entityThe American Journal of Medicine, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- The antineoplastic role of bisphosphonates: from basic research to clinical evidenceAnnals of Oncology, 2003
- Osteonecrosis of the jaws associated with cancer chemotherapyJournal of Oral and Maxillofacial Surgery, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Antitumor effects of bisphosphonatesCancer, 2003
- Osteoradionecrosis of the MandibleAmerican Journal of Clinical Oncology, 2002
- Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human boneJournal of Cellular Biochemistry, 1994